Dedicated to discovery & development of important medicines to transform the lives of patients & their families
Clinical Trials
Global Clinical Development
Ascentage Pharma is an integrated global biopharmaceutical company engaged in discovering, developing and commercializing both first- and best-in-class cancer therapies.
Learn more on ClinicalTrials.gov.
49 Clinical Trials Ongoing
-
AML/MDS
Lisaftoclax (APG-2575)
Study of APG-2575 Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML
MOLECULE: Lisaftoclax (APG-2575)
CONDITION: AML/MDS -
AML/MDS
Lisaftoclax (APG-2575)
A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacytidine in the Treatment of Acute Myeloid Leukemia
MOLECULE: Lisaftoclax (APG-2575)
CONDITION: AML/MDS -
AML/MDS
Lisaftoclax (APG-2575)
A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML)
MOLECULE: Lisaftoclax (APG-2575)
CONDITION: AML/MDS -
AML/MDS
Alrizomadlin (APG-115)
A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS
MOLECULE: Alrizomadlin (APG-115)
CONDITION: AML/MDS -
AML/MDS
Alrizomadlin (APG-115)
A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS.
MOLECULE: Alrizomadlin (APG-115)
CONDITION: AML/MDS -
Anemia
APG-5918
A Study to Investigate the Safety, Pharmacokinetics and Efficacy of APG-5918 in Healthy Subjects or Anemic Patients
MOLECULE: APG-5918
CONDITION: Anemia